Coronavirus and your health

Learn more about COVID-19 and diabetes.   |   Precautions for patients facing higher risks

2023 Episode 9 – New Science from AHA Scientific Sessions 2022 – CVD Risk Management in Patients with T2D

This podcast highlights the new science presented at the American Heart Association’s (AHA’s) Scientific Sessions in 2022. Jane Reusch, MD, Nathan Wong, PhD, MPH, and Chiadi Ndumele, MD, PhD, MHS discuss clinical highlights related to CVD risk management in patients with diabetes, including renal disease, and how to incorporate these findings into clinical practice.

Play the podcast in Apple Podcasts.

podcast player graphic

2023 Episode 9 – New Science from AHA Scientific Sessions 2022 – CVD Risk Management in Patients with T2D

KDBH Podcast – 2022 AHA New Science – Transcript

Jane E.B. Reusch, MD, FAHA, is Professor of Medicine, Bioengineering, and Integrative Physiology, and Associate Director of the Center for Women’s Health Research, Anschutz Medical Campus at the University of Colorado; Staff Physician and Merit Review Investigator at the Rocky Mountain Regional VAMC.  As a physician-scientist, Dr. Reusch has made fundamental contributions to our understanding of cellular metabolism of diabetes and its complications studying people with diabetes and cell and animal models. She has been elected to the American Society for Clinical Investigation and the American Association of Physicians, and awarded the Women of Valor in Diabetes Award, The Endocrine Society Laureate Award for Mentoring and the Banting Medal for Leadership and Service and Albert Renold Award from the American Diabetes Association. She served as President for Medicine and Science of the American Diabetes Association and on the ADA professional Practice Committee 2019-2021 (writing group for the ADA Standard of Medical Care for Diabetes).

Jane Reusch

Jane E. B. Reusch, MD, FAHA (Center for Women’s Health Research, Anschutz Medical Campus at the University of Colorado; Staff Physician and Merit Review Investigator at the Rocky Mountain Regional VAMC)

Nathan D. Wong, PhD, MPH, FACC, FAHA, FNLA, FASPC , is a cardiovascular epidemiologist and specialist in preventive cardiology. His primary research interests include subclinical atherosclerosis and epidemiology and management of dyslipidemia and diabetes in relation to cardiovascular disease.  Past/current investigator with numerous NIH observational studies on cardiovascular disease and clinical trials of lipid-lowering. Dr. Wong has authored over 400 papers and co-edited seven textbooks and is currently president of the InterAmerican Heart Foundation and past president of the American Society for Preventive Cardiology and Pacific Lipid Association Chapter of the NLA.

Nathan Wong

Nathan Wong, PhD, MPH, FACC, FAHA, FNLA, FASPC (Professor of Medicine and Director, Heart Disease Prevention Program, University of California, Irvine)

Chiadi Ndumele, MD, PhD, MHS, is Director of Obesity and Cardiometabolic Research for Johns Hopkins Cardiology. Dr. Ndumele is the Immediate Past Chair of the Obesity Committee of the American Heart Association (AHA), and current Vice-Chair of the AHA’s Lifestyle and Cardiometabolic Health Council. His research focuses on the impact of obesity and cardiometabolic risk factors on the development of cardiovascular disease, particularly heart failure, and strategies for heart failure prevention.

Chiadi Ndumele, MD, PhD, MHS

Chiadi Ndumele, MD, PhD, MHS (Assistant Professor of Medicine, Johns Hopkins University School of Medicine)